A Synthesis of Functionalized Benzimidazoles via the Three-Component Reaction of Terminal Alkynes, Phenylsulfonyl Azide, and Phenylenediamine-1,3-dicarbonyl Adducts
Synlett · 01.02.2026 · 37 (03) · 367-370
DOI: 10.1055/a-2735-9398 ↗Kurz gefasst
Fachartikel in der Zeitschrift Synlett, erschienen am 01.02.2026. Verfasst von Issa Yavari und 2 weiteren Autor:innen. Die Arbeit nennt 50 Literaturangaben. Gefördert von: Research Council of Tarbiat Modares University.
Abstract (Originalsprache)
Functionalized benzimidazoles are produced through a three-component reaction that combines phenylenediamine-1,3-dicarbonyl adducts, terminal alkynes, and phenylsulfonyl azide. This synthesis involves the generation of N-sulfonylketenimine intermediates via a copper-catalyzed azide-alkyne cycloaddition, which is subsequently followed by cyclization with the phenylenediamine-1,3-dicarbonyl adducts. The method is noted for its efficiency and versatility across a range of substrates, with the final compound’s structure being validated through single-crystal X-ray analysis.
Förderung
- Research Council of Tarbiat Modares University
Zitieren
APA
Yavari, I., Akbarzadeh, S., & Ghorbanzadeh, M. (2026). A Synthesis of Functionalized Benzimidazoles via the Three-Component Reaction of Terminal Alkynes, Phenylsulfonyl Azide, and Phenylenediamine-1,3-dicarbonyl Adducts. Synlett, 37(03), 367-370. https://doi.org/10.1055/a-2735-9398
Vancouver
Yavari I, Akbarzadeh S, Ghorbanzadeh M. A Synthesis of Functionalized Benzimidazoles via the Three-Component Reaction of Terminal Alkynes, Phenylsulfonyl Azide, and Phenylenediamine-1,3-dicarbonyl Adducts. Synlett. 2026;37(03):367-370. doi:10.1055/a-2735-9398
BibTeX
@article{Yavari2026,
author = {Yavari, Issa and Akbarzadeh, Somayeh and Ghorbanzadeh, Meysam},
title = {A Synthesis of Functionalized Benzimidazoles via the Three-Component Reaction of Terminal Alkynes, Phenylsulfonyl Azide, and Phenylenediamine-1,3-dicarbonyl Adducts},
journal = {Synlett},
year = {2026},
volume = {37},
number = {03},
pages = {367--370},
doi = {10.1055/a-2735-9398}
}
EUVIMED